Cano Health filed for bankruptcy this week — about three years after going public $4.4 billion SPAC merger. The industry reacted without surprise, with experts calling the bankruptcy a direct result of mismanagement, a quixotic growth strategy and poor market selection.
The complaint alleges that the program, which involves workers undergoing certain medical examinations and divulging health info in lieu of a weekly fine is a violation of the American with Disabilities Act and the Genetic Nondiscrimination Act.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The William K. Warren Foundation co-led the round with angel investor Kevin Ryan.
Yale spinout Arvinas just raised $41.6 million for its platform of protein degradation drugs - a different mechanism than the standard protein inhibition drugs on the market.
"Most high-risk medical devices are being approved on the basis of a single pivotal trial, and these trials have clear weaknesses," said Yale University public health researcher Joseph Ross.
Teens with type 1 diabetes can struggle to check blood sugar levels frequently enough once they are more autonomous, but small rewards can make a difference.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
It has a patent-pending “biochip” technology that analyzes and “fingerprints” single cells, studying their immune response: That is, the excretion of a number of proteins like cytokines, chemokines and growth factors.
Coffee drinkers could be lowering their chances of getting melanoma, the deadliest form of skin cancer, with each cup. Those of us who need a kick of caffeine throughout the work day will take what we can get in terms of random health benefits – even if we do spend most hours of the weekdays […]
Healthcare for men and women has many overlaps, but some new research has indicated that we actually differ in the way cigarettes could affect us, which could also result in gender-specific cessation programs. Researchers, who published a study earlier this month in the Journal of Neuroscience by author Kelly Cosgrove, Ph.D., of Yale University used PET […]
Antibiotic resistance is taking its toll on the pharmaceutical industry: Drugs are getting retired from clinical circulation, because many have basically been rendered ineffective, according to an article from Washington University of St. Louis. It highlights the work of WUSTL’s Michael Kinch, associated vice chancellor of its Center for Research Innovation in Business: The number […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
CMS announced the second batch of prospective recipients of its Health Care Innovation Awards, which brings the total amount of funding for the project to about $360 million for health systems that devise new, innovative ways to curb healthcare costs among high-risk patients. Prospective winners are selected based on “compelling new ideas to deliver better […]
A cancer drug startup spun out of the Yale School of Medicine has licensed the rights to develop and test a drug candidate from MedImmune designed to target a receptor that’s been connected to various cancers including breast, lung, ovary and colon. Kolltan Pharmaceuticals hopes to have its lead candidate, which targets the HER3 receptor […]
Three years ago, Yale University professor of molecular biophysics and biochemistry Thomas Steitz won the Nobel Prize in chemistry for his research on the structure and function of the ribosome. Now, the company that he co-founded to create new antibiotics that overcome drug resistance is preparing to enter phase 3 clinical trials. Rib-X Pharmaceuticals, the […]
Reducing the side effects and improving compliance in the millions of people who take aspirin regularly is the goal of a pharmaceutical company raising up to $7.7 million in anticipation of a 2013 NDA filing.
After raising a $3.2 million series A, a medical device startup that’s developed a tool for minimally invasive gallbladder and appendix removals is eyeing a mid-2013 launch. NovaTract Surgical Inc.’s initial product is an organ retraction device designed to reduce the number of incisions needed to perform minimally invasive surgeries of the abdomen. Traditionally, these […]